Nortech Systems Reports First Quarter Results

17:03 EDT 15 May 2019 | Businesswire

Nortech Systems Incorporated

Nortech Systems Incorporated (Nasdaq: NSYS), a leading provider of design and manufacturing solutions for complex electromechanical products, reported net sales of $28.2 million for the first quarter ended March 31, 2019, compared with $26.4 million for the first quarter of 2018.

Operating loss for the first quarter of 2019 was $104,000, which compares with an operating loss of $120,000 for the first quarter of 2018. Net loss for the first quarter of 2019 was $363,000, or $0.14 per diluted common share. This compares with a net loss for first quarter of 2018 of $391,000, or $0.14 per diluted common share.

The mission of Nortech Systems is to be the most trusted, innovative, and nimble design and manufacturing services and solutions provider, while taking great care of its employees, customers, and supplier partners.

About Nortech Systems Incorporated
Nortech Systems is a leading provider of design and manufacturing solutions for complex electromechanical systems, assemblies, and components. Nortech Systems primarily serves the medical, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire/cable/interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has seven manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is

Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. While this release is based on management’s best judgment and current expectations, actual results may differ and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: volatility in market conditions which may affect market supply of and demand for the company’s products; increased competition; changes in the reliability and efficiency of operating facilities or those of third parties; risks related to availability of labor; commodity and energy cost instability; general economic, financial and business conditions that could affect the company’s financial condition and results of operations; as well as risk factors listed from time to time in the company’s filings with the SEC.


Condensed Consolidated Statements of Operations
(in thousands, except for share data)

Unaudited   Unaudited
2019 2018
Net Sales $ 28,165 $ 26,447
Cost of Goods Sold 25,204   23,419  
Gross Profit 2,961   3,028  
10.5 % 11.4 %
Operating Expenses
Selling Expenses 761 1,039
General and Administrative Expenses 2,304   2,109  
Total Operating Expenses 3,065   3,148  
Loss From Operations (104 ) (120 )
Other Expense
Interest Expense (245 ) (172 )
Loss Before Income Taxes (349 ) (292 )
Income Tax Expense 14   99  
Net Loss $ (363 ) $ (391 )
Loss Per Common Share - Diluted $ (0.14 ) $ (0.14 )
Weighted Average Number of Common Shares Outstanding - Diluted 2,659,859   2,720,609  

Condensed Consolidated Balance Sheets
(in thousands)

MARCH 31, 2019 DECEMBER 31, 2018
Unaudited Audited
Cash $ 310 $ 480
Restricted Cash 427 467
Accounts Receivable 23,092 20,093
Inventories 15,984 17,004
Contract Assets 8,584 6,431
Prepaid Expenses and Other Current Assets 2,133 1,381
Property and Other Long-term Assets 9,886 10,178
Goodwill and Other Long-term Assets, Net 9,260 3,926
Total Assets $ 69,676 $ 59,960
Accounts Payable $ 21,140 $ 18,142
Other Current Liabilities 7,004 6,750
Long Term Line of Credit 11,294 9,264
Long-term Debt and Other Long-term Liabilities 9,308 4,714
Shareholders’ Equity 20,930 21,090
Total Liabilities and Shareholders’ Equity $ 69,676 $ 59,960

Connie Beck, VP & CFO
Nortech Systems Incorporated
(952) 345-2244
Warren Djerf
Brookside Communications Group
(952) 920-3908 or


More From BioPortfolio on "Nortech Systems Reports First Quarter Results"

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...